| MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer P Ji, S Diederichs, W Wang, S Böing, R Metzger, PM Schneider, N Tidow, ... Oncogene 22 (39), 8031-8041, 2003 | 2614 | 2003 |
| Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ... Cancer cell 23 (2), 186-199, 2013 | 451 | 2013 |
| Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells C Müller-Tidow, B Steffen, T Cauvet, L Tickenbrock, P Ji, S Diederichs, ... Molecular and cellular biology 24 (7), 2890-2904, 2004 | 390 | 2004 |
| The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ... The Journal of clinical investigation 123 (2), 2013 | 269 | 2013 |
| S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer S Diederichs, E Bulk, B Steffen, P Ji, L Tickenbrock, K Lang, KS Zänker, ... Cancer research 64 (16), 5564-5569, 2004 | 249 | 2004 |
| Topoisomerase IIα in chromosome instability and personalized cancer therapy T Chen, Y Sun, P Ji, S Kopetz, W Zhang Oncogene 34 (31), 4019-4031, 2015 | 236 | 2015 |
| Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy Y Wang, P Ji, J Liu, RR Broaddus, F Xue, W Zhang Molecular cancer 8, 1-13, 2009 | 213 | 2009 |
| Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells P Ji, S Agrawal, S Diederichs, N Bäumer, A Becker, T Cauvet, S Kowski, ... Oncogene 24 (16), 2739-2744, 2005 | 164 | 2005 |
| 3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk HJ Park, P Ji, S Kim, Z Xia, B Rodriguez, L Li, J Su, K Chen, CP Masamha, ... Nature genetics 50 (6), 783-789, 2018 | 160 | 2018 |
| MiR‐506 suppresses proliferation and induces senescence by directly targeting the CDK4/6–FOXM1 axis in ovarian cancer G Liu, Y Sun, P Ji, X Li, D Cogdell, D Yang, BC Parker Kerrigan, ... The Journal of pathology 233 (3), 308-318, 2014 | 144 | 2014 |
| The cyclin A1-CDK2 complex regulates DNA double-strand break repair C Müller-Tidow, P Ji, S Diederichs, J Potratz, N Bäumer, G Köhler, ... Molecular and cellular biology 24 (20), 8917-8928, 2004 | 141 | 2004 |
| NGAL decreases E-cadherin-mediated cell–cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells L Hu, W Hittelman, T Lu, P Ji, R Arlinghaus, I Shmulevich, SR Hamilton, ... Laboratory investigation 89 (5), 531-548, 2009 | 136 | 2009 |
| Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ... JNCI: Journal of the National Cancer Institute 107 (7), djv108, 2015 | 134 | 2015 |
| An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability L Li, KL Huang, Y Gao, Y Cui, G Wang, ND Elrod, Y Li, YE Chen, P Ji, ... Nature genetics 53 (7), 994-1005, 2021 | 133 | 2021 |
| Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression KM Turner, Y Sun, P Ji, KJ Granberg, B Bernard, L Hu, DE Cogdell, ... Proceedings of the National Academy of Sciences 112 (11), 3421-3426, 2015 | 129 | 2015 |
| MiR‐506 inhibits multiple targets in the epithelial‐to‐mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer Y Sun, L Hu, H Zheng, M Bagnoli, Y Guo, R Rupaimoole, ... The Journal of pathology 235 (1), 25-36, 2015 | 126 | 2015 |
| Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma X Li, Y Liu, KJ Granberg, Q Wang, LM Moore, P Ji, J Gumin, EP Sulman, ... Oncogene 34 (13), 1619-1628, 2015 | 113 | 2015 |
| The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non–small cell lung cancer J Yu, E Bulk, P Ji, A Hascher, M Tang, R Metzger, A Marra, H Serve, ... Clinical Cancer Research 16 (8), 2275-2283, 2010 | 99 | 2010 |
| Identification of interaction partners and substrates of the cyclin A1-CDK2 complex S Diederichs, N Bäumer, P Ji, SK Metzelder, GE Idos, T Cauvet, ... Journal of Biological Chemistry 279 (32), 33727-33741, 2004 | 88 | 2004 |
| Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients Y Chu, N Elrod, C Wang, L Li, T Chen, A Routh, Z Xia, W Li, EJ Wagner, ... Oncogene 38 (21), 4154-4168, 2019 | 73 | 2019 |